2. INTRODUCTION
• RA is a chronic, progressive, autoimmune,
inflammatory disease affecting joints
• Mediators of inflammation released initiate
inflammatory process
3. CLASSIFICATION
I. NSAIDs
II. DMARDs
A. Immunosuppressants
– Methotrexate
– Cyclophosphamide
– Azathioprine
– Cyclosporine
– Leflunomide
– Chloroquine, Hydroxychloroquine
4. B. Biological agents-
• Etanercept
• Infliximab
• Adalimumab
• Certolizumab
• Golimumab
TNFα blockers
• Abatacept
Inhibitors of T cell
activation
• AnakinraIL1 antagonist
• Rituximab
Anti B lymphocyte
antibody
• KanakinumabIL1 B antibody
• TocilizumabIL6 antagonist
5. • First line drugs
• Symptomatic relief
• Toxicity with long term use
• Eg- Aspirin, Ibuprofen, Naproxen, Diclofenac,
Piroxicam
I. NSAIDs
6. • For patients who do not obtain satisfactory
relief from NSAIDs
• Capable of arresting progress of disease
• Effects take 6wks to 6 months
• Also called SAARDs
II. DMARDs
9. 2. AZATHIOPRINE
• Purine analogue
• Prodrug
• Converted to 6-thioguanine in body
• Suppresses cell mediated immunity
• Alternative to methotrexate
DOSE-
AZORAN 25mg tab
AZAP 50mg tab
10. 3. CYCLOPHOSPHAMIDE
• Alkylating agent
• Inhibits T and B cell function
• Orally in RA, autoimmune diseases
DOSE-
• CYPHOS, NEOPHOS 200,500mg, 1g inj
• ONCOMIDE 50mg tab, 200,500mg, 1g vial
11. 4. LEFLUNOMIDE
Prodrug
Active metabolite inhibits T cell proliferation and
productionof autoantibodies by B cells
Orally effective
T1/2- 5-40days
ADR- Diarrhoea, wt gain, hypertension, alopecia
12. 5. HYDROXYCHLOROQUINE,
CHLOROQUINE
• Antimalarial drugs useful in RA
• Can accumulate in tissues leading to toxicity
• Side effect- retinal damage
• Dose- CADIQUIN 250, 500mg tab, LAROVER
250mg tab
13. a) TNFα blocking agents
(i) Infliximab
Monoclonal
antibody
Slows
progression of
RA
IV infusion 3-
5mg/kg every
8hr
T1/2- 9-
12days
ADR- Nausea,
headache,
rash, cough
REMICADE
10mg vial
15. b) Inhibitor of T
cell activation-
Abatacept
•T1/2- 13-16 days
•IV infusion- 800-
1000mg
•Repeated 2 and
4wks
c) IL1 antagonist-
Anakinra
•Pts not resp to
DMARDs
17. a) Gold salts
• Not preferred- toxicity
• Eg- Auranofin, Aurathiomalate
MOA- Depress cell mediated immunity
DOSE- 6mg/day, GOLDAR 3mg tab
ADR- Hepatotoxicity, Nephrotoxicity, Dermatitis,
Encephalitis
III. OTHER ANTI RHEUMATIC DRUGS
18. b) d-Penicillamine
• Metabolite of penicillin
• Toxicity- same as gold, not preferred
c) Sulphasalazine
• Anti inflammatory
• ADR- GI upset, skin rashes
• Dose- 500-1000mg bd-tds
• IWATA 500mg tab